Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/.
As 2023 comes to a close, Jay Rughani, investment partner at Andreessen Horowitz, joined MobiHealthNews to discuss his takeaways from the year, noteworthy events, recommendations for regulators forming rules around AI in...
At the HIMSS AI in Healthcare Forum in San Diego on Dec. 14, a group of panelists outlined tactical pathways to artificial intelligence adoption and investment, including how to maximize impact and decisions around adopting existing tools or building new AI infrastructure.
Anne Snowdon, CEO of Scan Health and chief research officer at HIMSS, said that determining strategic priorities and setting...
The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes.
With an estimated valuation of $15.1 billion for the global market in 2022, AI in healthcare is an irreversible process that is already reshaping medicine and...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Dr. Michael Howell, chief clinical officer at Google, sat down with MobiHealthNews to discuss noteworthy events in 2023, the evolution of the company's LLM for healthcare, called Med-PaLM, and recommendations for regulators in constructing rules around the use of artificial intelligence in the sector.
MobiHealthNews: What are some of your big takeaways from 2023?
Dr. Michael Howell: For us,...
GE HealthCare is leveraging AI and data integration technologies to help tackle the rapidly increasing volume of patient data and working to optimize the application of these two tech tools in patient care in announcing 40 new innovations at RSNA23.
The company's central strategy is to integrate AI into its precision care framework, encompassing smart devices, targeted therapies, disease-...
AI-enabled imaging company Aidoc announced that it has secured $30 million in funding to develop a comprehensive AI imaging model and a new category of products based on that model.
WHAT IT DOES
Aidoc offers radiologists tools to find and triage injuries and health conditions based on imaging results. It also provides coordination software for stroke and cardiovascular care, alerting relevant...
Royal Philips made several announcements at RSNA23 in Chicago yesterday, including the release of its next-generation AI-enabled advanced visualization workspace, its AI Manager and the BlueSeal MR Mobile Unit.
The company's visualization workspace for health systems is an AI-powered offering aimed at improving workflows using a single platform for multiple modalities. The company said it helps...
OpenAI's GPT-4 correctly diagnosed 52.7% of complex challenge cases, compared to 36% of medical journal readers, and outperformed 99.98% of simulated human readers, according to a study published by the New England Journal of Medicine.
The evaluation, conducted by researchers in Denmark, utilized GPT-4 to find diagnoses pertaining to 38 complex clinical case challenges with text information...
Direct-to-consumer virtual care company Hims & Hers Health announced last week the launch of a new AI-enabled offering, MedMatch, which provides healthcare providers with anonymized data points generated from the company's customer database, aimed at helping mental health professionals identify suitable treatments for patients.
Dr. Patrick Carroll, chief medical officer at Hims & Hers,...
def4.jpg "Person answering their front door and getting a delivery from another person")
